Skip directly to content

Pfizer in the UK

Working together for Britain’s national health

Pfizer is one of the world’s premier innovative biopharmaceutical companies, discovering, developing and providing over 120 different medicines, vaccines and consumer healthcare products to help save and improve the lives of almost 3 million people in the UK every day.

We have around 2,800 colleagues in four locations in the UK working across our commercial business, research and development (R&D) and manufacturing, packaging and distribution.

Together Works Better

We firmly believe that innovation comes from working alongside others in effective partnership.  We work with organisations from  across the UK healthcare spectrum, including the NHS, healthcare providers, academia, patient organisations, non-governmental organisations (NGOs) and  UK government, sharing knowledge, skills and expertise to improve the health and lives of people in the UK and around the world.

» Read more about how we collaborate and work with others

Our Business in the UK

Pfizer Limited, is the principal UK subsidiary of Pfizer Inc and is divided into four divisions:

Tab 1

Maecenas tincidunt in nulla a lacinia. Vivamus ut ultrices nibh. Vestibulum vel augue aliquet, elementum libero vitae, feugiat dolor. Aliquam malesuada imperdiet nibh. Etiam quis odio ac nibh porttitor sagittis. Nunc a congue velit, et commodo ipsum. Aliquam aliquam dictum faucibus. Proin non tempus nisi. Mauris cursus sollicitudin sagittis.

Tab 2

Maecenas tincidunt in nulla a lacinia. Vivamus ut ultrices nibh. Vestibulum vel augue aliquet, elementum libero vitae, feugiat dolor. Aliquam malesuada imperdiet nibh. Etiam quis odio ac nibh porttitor sagittis. Nunc a congue velit, et commodo ipsum. Aliquam aliquam dictum faucibus. Proin non tempus nisi.

Tab 3

Maecenas tincidunt in nulla a lacinia. Vivamus ut ultrices nibh. Vestibulum vel augue aliquet, elementum libero vitae, feugiat dolor. Aliquam malesuada imperdiet nibh. Etiam quis odio ac nibh porttitor sagittis. Nunc a congue velit, et commodo ipsum.

Biopharmaceutical Business

Our biopharmaceutical business is divided into four Business Units, each of which broadly work in different areas of medicine. These Business Units are Primary Care, Specialty Care, Oncology and Established Products.

Each Business Unit works with the regulators, the NHS and healthcare professionals, such as GPs, specialists, nurses and pharmacists, to help get our medicines to the patients who need them. Every day, our medicines and vaccines are taken by around 2.7 million people.

The work of these Business Unit teams actually starts right back in the lab. Business Unit colleagues work with our R&D teams to take compounds that we have discovered and have shown “proof of concept” and develop these into licensed medicines, with proven safety and efficacy, so that they can be used by healthcare professionals to help treat patients. 

Through our Established Products Business Unit, we continue to support the medicines in our portfolio even after they are no longer patent protected, to ensure that the NHS and patients can continue to benefit from them for years to come.

Globally, Pfizer has announced plans to internally separate its commercial operations into three business in 2014. These will be the Innovative Pharmaceutical Business, the Vaccines, Oncology and Consumer Healthcare Business, and the Established Pharmaceutical Business.

» Read more about our Biopharmaceutical Business

Research & Development

At Pfizer we invest time, knowledge, money and people to find new life-saving or life-changing medicines. We have more than 800 scientists, researchers and doctors in the UK, all working on the goal of finding new medicines and treatments and getting them safely to healthcare professionals and patients, to improve people’s health.

Our research and development colleagues in Cambridge and Sandwich work with other colleagues across the world, as well as universities and academia, other companies and other organisations in the search for, and development of, new medicines and treatments.

In 2012 alone, Pfizer invested £182 million and enrolled around 370 patients into 91 clinical trials in the UK. Over the last decade, we have invested £5 billion in research in the UK to develop medicines and vaccines to improve Britain’s health. This is almost a third of the total spend in R&D in the UK.   

» Read more about Research & Development in the UK

Consumer Health

At Pfizer Consumer Healthcare, we are committed to delivering quality Over The Counter (OTC) products to consumers around the world.

All of Pfizer Consumer Healthcare products are put through rigorous and stringent checks to ensure that they comply with the quality standards according to the Global Good Manufacturing Practice Manual. These quality standards are applied company-wide globally across USA, Europe and Asia Pacific.

We test each and every batch of products before they are put onto the market to ensure that the products are of the highest quality so that you can take and recommend Pfizer Consumer Healthcare products with full confidence.

Pfizer Global Supply

Pfizer’s packaging and distribution site in Havant, is a centre of excellence for  controlled cold chain medicines (medicines that must be kept below a certain temperature from the point of manufacture until they reach the patient).

The site packages and distributes temperate sensitive vaccines and injectable medicines to countries right across the world.